# Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma

> **NCT04419441** · — · UNKNOWN · sponsor: **Ospedale Maggiore Di Trieste** · enrollment: 12 (estimated)

## Conditions studied

- Hodgkin Lymphoma
- Immune Checkpoint Inhibitor
- Radiotherapy

## Interventions

- **DRUG:** Immune checkpoint inhibitor

## Key facts

- **NCT ID:** NCT04419441
- **Lead sponsor:** Ospedale Maggiore Di Trieste
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-24
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04419441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04419441, "Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04419441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*